Biogen Inc (NASDAQ:BIIB)

264.80
Delayed Data
As of Oct 22
 -5.41 / -2.00%
Today’s Change
223.25
Today|||52-Week Range
468.55
+8.14%
Year-to-Date
There's Money to Be Made With Vertex, Viatris, Incyte and Biogen
10:54am / GuruFocus News - Paid Partner Content
Sage, Biogen Plan to File Zuranolone NDA for MDD in 2022
Oct 20 / Zacks.com - Paid Partner Content
3 Big Problems With Biogen's Q3 Results
Oct 23 / MotleyFool.com - Paid Partner Content
Biogen (BIIB) Q3 Earnings Top, Aduhelm Sales Negligible
Oct 20 / Zacks.com - Paid Partner Content
Why Ionis Pharmaceuticals Stock Is Down 13% This Week
Oct 22 / MotleyFool.com - Paid Partner Content
Biogen Inc. (BIIB) Q3 Earnings and Revenues Surpass Estimates
Oct 20 / Zacks.com - Paid Partner Content
Biogen inc (BIIB) Q3 2021 Earnings Call Transcript
Oct 20 / MotleyFool.com - Paid Partner Content
2 Stocks That Could Grow Your Portfolio Over the Next Decade
Oct 20 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: BIIB's Q3 Earnings, REGN's COVID-19 Cocktail Update & More
Oct 20 / Zacks.com - Paid Partner Content
3 Biotech Stocks That Are Ridiculously Overpriced
Oct 20 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close270.21
Today’s open269.38
Day’s range264.44 - 269.66
Volume41,345
Average volume (3 months)1,208,002
Market cap$38.9B
Data as of 4:00pm ET, 10/22/2021

Growth & Valuation

Earnings growth (last year)-21.00%
Earnings growth (this year)-43.51%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)-2.82%
P/E ratio25.3
Price/Sales3.20
Price/Book3.77

Competitors

----
TECHBio-Techne Corp+7.30+1.47%
ILMNIllumina Inc-2.68-0.65%
EXASExact Sciences Corp-2.21-2.30%
Data as of 4:00pm ET, 10/22/2021

Financials

Next reporting dateJanuary 27, 2022
EPS forecast (this quarter)$3.32
Annual revenue (last year)$12.4B
Annual profit (last year)$4.0B
Net profit margin32.38%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts